MultiModal Imaging Services Corporation (dba HealthLytix)

MultiModal Imaging Services Corporation (dba HealthLytix) has 1 AI-enabled medical device on the FDA list. The first decision was on November 19, 2019 and the most recent on November 19, 2019 (RSI-MRI+). Its most common review panel is Radiology (1 device).